久久精品99_国产精品视频免费一区_91精品视频播放_国产伦精品一区二区三区视频免费

CANCER IMMUNOLOGY IMMUNOTHERAPY

CANCER IMMUNOLOGY IMMUNOTHERAPY

癌癥免疫學免疫療法

期刊周期:Monthly
研究方向:醫學
影響因子:4.9
通訊地址:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
官網:http://www.springer.com/medicine/internal/journal/262
投稿地址:https://www.editorialmanager.com/ciim/default.aspx
審稿速度:平均1月

  CANCER IMMUNOLOGY IMMUNOTHERAPY期刊中文簡介

自1976年成立以來,腫瘤免疫學、免疫治療(CII)在腫瘤免疫學領域取得了重大進展。該雜志是一個論壇的新概念和進展的基礎,翻譯,臨床癌癥免疫學和免疫治療。CII熱衷于發表廣泛的觀點和評論,擴展或挑戰現有范式的結果,以及未能復制支持當前范式的實驗的負面研究,以及在不同環境中成功復制他人結果的論文。除了發表原創研究論文和評論,CII還提供以下獨特的出版格式:·“聚焦研究綜述”,與會議報告一起發表,為每位演講者提供了機會來擴展他們在會議上提出的想法和概念。·“書面研討會”,是一系列圍繞某一特定問題并針對該領域有爭議但具有戰略意義的主題的補充論文組成的虛擬研討會,通常由4-8篇論文和召集人的附帶評論組成。CII隸屬于癌癥免疫治療協會(CIMT)、加拿大癌癥免疫治療協會(CCIC)、日本癌癥免疫協會(JACI)、意大利生物腫瘤免疫治療網絡(NIBIT)、免疫腫瘤免疫治療和免疫監測協會(CITIM)。

  CANCER IMMUNOLOGY IMMUNOTHERAPY期刊英文簡介

Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology. The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, as well as negative studies which fail to reproduce experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts.In addition to publishing original research articles and reviews, CII also offers the following unique publication formats:·“Focussed Research Reviews,” published together with a conference meeting report, which provide individual speakers with the opportunity to expand on the ideas and concepts they presented at the conference.·“Symposia-in-Writing,” which are virtual workshops consisting of a series of complimentary papers centered on a specific issue and addressing controversial but strategic topics in the field, usually consisting of 4-8 papers and an accompanying commentary by the convener. CII is affiliated with the Association for Cancer Immunotherapy (CIMT), Canadian Cancer Immunotherapy Consortium (CCIC), The Japanese Association for Cancer Immunology (JACI), Network Italiano per la Bioterapia dei Tumori (NIBIT), Sociedad Espa?ola de Immunologia-Grupo Espa?ol de ImmunoTerapia (SEI-GEIT), and Cancer Immunotherapy & Immunomonitoring (CITIM).

  CANCER IMMUNOLOGY IMMUNOTHERAPY近年期刊影響因子趨勢圖

  相關醫學SCI期刊推薦

SCI服務

搜論文知識網 冀ICP備15021333號-3

主站蜘蛛池模板: 欧美日本国产在线| 久久久久久91| 热草久综合在线| 三级三级久久三级久久18| 天天操天天干天天玩| 日韩在线视频网| 亚洲欧美久久234| 国产啪精品视频| 日韩视频第二页| 日韩中文字幕一区| 国产精品亚洲综合天堂夜夜| 久久久精品美女| 在线精品亚洲一区二区| 美女在线免费视频| 欧美一区二区视频97| 一区二区不卡视频| 国产精品初高中精品久久| 久久在线中文字幕| 日韩欧美亚洲日产国| 国产精品美女久久久免费| 久久在线中文字幕| 国产精品美女视频网站| 国产福利精品视频| 欧美激情一级欧美精品| 精品国产福利| 国产超级av在线| 日韩中文在线中文网三级| 久久久精品在线观看| 天堂资源在线亚洲视频| 日韩视频专区| 麻豆av一区二区三区久久| 91精品国产99久久久久久| 久久本道综合色狠狠五月| 国产精品国产亚洲精品看不卡15| 国产精品av免费在线观看| 91精品国产91久久久久青草| 人人妻人人澡人人爽精品欧美一区| 欧美激情中文网| 亚洲色欲久久久综合网东京热| 国产美女精品视频| 国产精品美女久久久久av超清|